TAF1D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.180200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.274400E-01
Normal-vs-Stage2
6.140200E-01
Normal-vs-Stage3
2.524400E-01
Normal-vs-Stage4
4.986000E-01
Stage1-vs-Stage2
6.333600E-01
Stage1-vs-Stage3
7.717200E-01
Stage1-vs-Stage4
8.186000E-01
Stage2-vs-Stage3
4.503800E-01
Stage2-vs-Stage4
9.046200E-01
Stage3-vs-Stage4
3.603400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.652000E-01
Normal-vs-AfricanAmerican
1.565950E-01
Normal-vs-Asian
3.121400E-01
Caucasian-vs-AfricanAmerican
3.920400E-01
Caucasian-vs-Asian
6.106400E-01
AfricanAmerican-vs-Asian
5.414600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.701000E-01
Normal-vs-Female
3.166200E-01
Male-vs-Female
1.547440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.358600E-01
Normal-vs-Age(41-60Yrs)
5.450600E-01
Normal-vs-Age(61-80Yrs)
4.673800E-01
Normal-vs-Age(81-100Yrs)
8.138400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.639700E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.966960E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.022000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.211400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.019630E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.804000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.126400E-01
Normal-vs-Daily Drinker
7.959600E-01
Normal-vs-Weekly Drinker
2.369000E-01
Normal-vs-Occasional Drinker
6.575600E-01
Normal-vs-Social Drinker
2.992800E-01
Non Drinker-vs-Daily Drinker
7.225000E-01
Non Drinker-vs-Weekly Drinker
4.096600E-01
Non Drinker-vs-Occasional Drinker
6.090600E-01
Non Drinker-vs-Social Drinker
5.226600E-01
Daily Drinker-vs-Weekly Drinker
3.428600E-01
Daily Drinker-vs-Occasional Drinker
9.888400E-01
Daily Drinker-vs-Social Drinker
4.225000E-01
Weekly Drinker-vs-Occasional Drinker
1.966010E-01
Weekly Drinker-vs-Social Drinker
8.496400E-01
Occasional Drinker-vs-Social Drinker
2.714400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.520990E-01
Normal-vs-Grade 2
1.592170E-02
Normal-vs-Grade 3
6.237500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.916100E-03
Grade 1-vs-Grade 3
1.198750E-03
Grade 1-vs-Grade 4
1.520990E-01
Grade 2-vs-Grade 3
9.712100E-02
Grade 2-vs-Grade 4
1.592170E-02
Grade 3-vs-Grade 4
6.237500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.378400E-01
Normal-vs-NonDiabetic
5.027200E-01
Diabetic-vs-NonDiabetic
7.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.510200E-01
Normal-vs-NoPancreatitis
5.054400E-01
Pancreatitis-vs-NoPancreatitis
4.642400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.541400E-01
Normal-vs-N1
4.990000E-01
N0-vs-N1
4.449200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.182400E-01
Normal-vs-TP53-NonMutant
4.710600E-01
TP53-Mutant-vs-TP53-NonMutant
2.236200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
